What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Alzheimer's disease
The scientist’s investigation covers issues in Alzheimer's disease, Dementia, Internal medicine, Pathology and Disease.
His Alzheimer's disease research is multidisciplinary, relying on both Clinical trial, Psychiatry, Immunology, Parkinsonism and Degenerative disease.
The Clinical trial study which covers Randomized controlled trial that intersects with Neuroimaging, Neurocognitive, REM sleep behavior disorder and Intensive care medicine.
His Dementia research incorporates elements of Neuropathology, Neuroscience and Gerontology.
His Internal medicine research includes elements of Endocrinology and Oncology.
Disease is closely attributed to Genetic variation in his work.
His most cited work include:
- Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium (1355 citations)
- Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium (1355 citations)
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (1050 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Dementia, Internal medicine, Disease, Alzheimer's disease and Pathology.
His Dementia study incorporates themes from Neuropathology, Psychiatry, Cognition and Parkinson's disease.
His Internal medicine research integrates issues from Endocrinology and Oncology.
James B. Leverenz focuses mostly in the field of Disease, narrowing it down to matters related to Immunology and, in some cases, Neurodegeneration.
The concepts of his Alzheimer's disease study are interwoven with issues in Age of onset, Single-nucleotide polymorphism, Neuroscience, Cognitive decline and Degenerative disease.
His Senile plaques, Autopsy, Amyloid and Pathogenesis investigations are all subjects of Pathology research.
He most often published in these fields:
- Dementia (38.03%)
- Internal medicine (40.43%)
- Disease (38.03%)
What were the highlights of his more recent work (between 2018-2021)?
- Disease (38.03%)
- Dementia (38.03%)
- Internal medicine (40.43%)
In recent papers he was focusing on the following fields of study:
James B. Leverenz focuses on Disease, Dementia, Internal medicine, Oncology and Immunology.
His Disease research is mostly focused on the topic Dementia with Lewy bodies.
James B. Leverenz combines subjects such as Clinical trial, Gerontology, Geriatric psychiatry, Randomized controlled trial and Intensive care medicine with his study of Dementia with Lewy bodies.
He works in the field of Dementia, namely Lewy body.
His Oncology research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Clinical Dementia Rating, Plasma biomarkers, Inflammatory pathways and Mild cognitive impairment.
His research in Alzheimer's disease tackles topics such as Genetics which are related to areas like Presenilin.
Between 2018 and 2021, his most popular works were:
- Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. (79 citations)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (61 citations)
- Key inflammatory pathway activations in the MCI stage of Alzheimer's disease. (12 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Alzheimer's disease
His primary areas of study are Disease, Dementia, Internal medicine, Dementia with Lewy bodies and Cognitive decline.
He performs integrative study on Disease and Epiphenomenon.
His research in Dementia intersects with topics in TREM2 and Neurology.
James B. Leverenz frequently studies issues relating to Oncology and Internal medicine.
His study in Dementia with Lewy bodies is interdisciplinary in nature, drawing from both Geriatric psychiatry, Gerontology and Intensive care medicine.
His Alzheimer's Disease Neuroimaging Initiative study also includes fields such as
- Biomarker that intertwine with fields like Clinical trial,
- Young adult, Down syndrome and Neuropathology most often made with reference to Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
